Prediabetes pp 287-295 | Cite as

Effect of Alpha-Inhibitors on Blood Glucose and Insulin Levels

  • H. Laube
  • K. Federlin
  • I. Hillebrand
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 246)


Modification and delay of carbohydrate absorption is a highly effective mechanism in treating postprandial hyperglycemia in diabetes mellitus. Slowing down and lowering blood sugar rise reduces the unwanted and dangerous process of protein glycation, which contributes to the extent and onset of diabetic late complications (1).


Beta Cell High Protein Diet Postprandial Hyperglycemia Carbohydrate Absorption Urinary Glucose Excretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Laube, H., Pfeiffer, E.F., 1978, Insulin secretion and the role of nutritional factors. In: Advances in Modern Nutrition. Katzen & Mahler, Eds., Hemisphere Publishing Corp. Vol. 2: 395.Google Scholar
  2. 2.
    Schmidt, D.D., Frommer, W., Junge, B., Muller, L., Wingender, W., Truscheit, E., 1982, Alpha-glucosidase inhibitors of microbial origin. Proc. First Int. Symp. Acarbose.Google Scholar
  3. 3.
    Hillebrand, I., Boehme, K. Graefe, K., Webling, K., 1986, The effect of new alpha-glucosidase inhibitors (Bay m 1099 and Bay o 1248) on meal- stimulated increase in glucose and insulin levels in man. Klin Wschr 64: 393.PubMedCrossRefGoogle Scholar
  4. 4.
    Laube, H., 1983, The clinical importance of delayed intestinal carbohydrate absorption. In: Delaying absorption as a therapeutic principle in metabolic diseases. Theime Verl. Creutzfeld/Folsch, eds., 136.Google Scholar
  5. 5.
    Schwedes, U., Petzold, R., Hillebrand, I., Schoffling, K., 1980, Comparison of metformin and acarbose treatment in non-insulin dependent diabetics. La din dietolog 7: 450.Google Scholar
  6. 6.
    Federlin, K.F., Mehlburger, L, Hillebrand, I., Laube, H., 1987, The effect of new alpha-glucosidase inhibitors on blood glucose in healthy volunteers and in Type II diabetics. Acta diabetol. lat.24: 213.PubMedCrossRefGoogle Scholar
  7. 7.
    Caspary, W.F., Lembcke, B., Creutzfeld, W., 1982, Inhibition of human intestinal a-glucoside hydrolase activity by acarbose and clinical consequences. Proc. First Int. Symp. Acarbose, Excerpta Medica, Int. Congr. Ser. 594: 27.Google Scholar
  8. 8.
    Lembcke, B., Folsch, U.R., Caspary, W.F., Creutzfeldt, W., 1982, Influence of metronidazol on intestinal side effects of acarbose. Proc. First Int. Symp., Acarbose. Excerpta Medica Int. Congr. Series 594: 236.Google Scholar
  9. 9.
    Sachse, G., Maser, Laube, H., Federlin, K., 1982, Effect of long- term acarbose therapy on the metabolic situation of sulfonylurea-treated diabetics. Proc. First Int. Symp. Acarbose. Excerpta Medica Int. Congr. Series 594: 5.Google Scholar
  10. 10.
    Laube, H., Aubell, R., Schmitz, H, Federlin, K., 1982, Acarbose, an effective therapy in lowering postprandial hyperglycemia in obese patients with Type II diabetes mellitus. Proc. First Int. Symp. Acarbose. Excerpta Medica, Int. Congr. Ser. 594: 344.Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • H. Laube
    • 1
  • K. Federlin
    • 1
  • I. Hillebrand
    • 1
  1. 1.Department of Internal MedicineUniversity of GlessenFRG

Personalised recommendations